Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emdogain in Transcrestal Sinus Lifting
NCT05507047Phase 4Completed
- Sponsor
- Kütahya Dumlupınar University
- Start
- Jan 2017
- Primary completion
- Jan 2020
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of enamel matrix derivative in partial edentulism, Alveolar bone atrophy (ABL), sponsored by Kütahya Dumlupınar University. Started Jan 2017; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
partial edentulismAlveolar bone atrophy (ABL)
Beyond the preview
Go deeper on NCT05507047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507047.